Premium
Genetic Variation in ABC G5/G8 and NPC1L1 Impact Cholesterol Response to Plant Sterols in Hypercholesterolemic Men
Author(s) -
Zhao Hai L.,
Houweling Adrielle H.,
Vanstone Catherine A.,
Jew Stephanie,
Trautwein Elke A.,
Duchateau Guus S. M. J. E.,
Jones Peter J. H.
Publication year - 2008
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/s11745-008-3241-y
Subject(s) - cholesterol , single nucleotide polymorphism , sterol , haplotype , allele , biology , medicine , endocrinology , clinical chemistry , genotype , lipoprotein , genetics , chemistry , gene
ATP‐binding cassette hetero‐dimeric transporters G5 and G8 ( ABCG5/G8 ) have been postulated to mediate intestinal cholesterol efflux, whereas Niemann‐Pick C1 Like 1 (NPC1L1) protein is believed to be essential for intestinal cholesterol influx. The individual or combined genetic markers, such as single nuclear polymorphisms (SNPs), of these two transporter genes may explain inter‐individual variations in plasma cholesterol response following plant sterol (PS) intervention. The present study was aimed at investigating the association between ABCG5/G8 and NPC1L1 genotype SNPs with sterol absorption and corresponding plasma concentrations. The study used a 4‐week crossover design with 82 hypercholesterolemic men characterized by high vs. low basal plasma PS concentrations consuming spreads with or without 2 g/day of PS. For the ABCG8 1289 C > A (T400 K) polymorphism, the A allele carriers with high basal plasma PS concentrations demonstrated a 3.9‐fold greater reduction ( p < 0.05) in serum low density lipoprotein cholesterol (LDL‐C) than their low basal plasma PS counterparts. For the NPC1L1 haplotype of 872 C > G (L272L) and 3929 G > A (Y1291Y), individuals carrying mutant alleles showed a 2.4‐fold greater ( p < 0.05) reduction in LDL‐C levels, compared to wild type counterparts. Results suggest that genetic and metabolic biomarkers together may predict inter‐individual lipid level responsiveness to PS‐intervention, and thus could be useful in devising individualized cholesterol lowering strategies.